Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas

Clinical trial NCT04656730 · COMPLETED

Trial details

NCT number: NCT04656730
Sponsor: Hospital Vall d'Hebron
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Irritable Bowel Syndrome Functional Dyspepsia

Start date: 2020-09-03
Primary completion: 2023-01-31
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.